Drug 1 for Birth Control
Study Summary
This trial is examining how different doses of progesterone-only pills affect the body.
Eligibility Criteria
Inclusion Criteria
You will be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Awards & Highlights
Trial Design
Find a site
Who is running the clinical trial?
Frequently Asked Questions
Are there any remaining vacancies for this medical experiment?
"Affirmative. Data posted on clinicaltrials.gov affirm that this medical experiment, initially posted on July 22nd 2022, is presently recruiting participants. 6 individuals need to be sourced from one facility for the trial's completion."
Does the research allow for geriatric patients to participate?
"The upper-age limit for this trial has been set at 55 years, whilst the lower age is 18."
What is the total number of participants in this research endeavor?
"Affirmative. Clinicaltrials.gov attests that this clinical trial is actively searching for participants, with the initial post being made on July 22nd 2022 and most recently modified on August 4th 2022. 6 people need to be recruited from one medical centre."
What potential hazards should patients be aware of when taking Drug 1?
"Based on previous clinical trials and the current Phase 4 status of Drug 1, our team at Power estimates it's safety to be a 3."
Am I eligible to be a test subject in this clinical experiment?
"This medical research is recruiting 6 patients from 18 to 55 years old, all of whom are actively using contraception. To be eligible for the study, participants must have menstrual cycles between 24-34 days in length, use non-hormonal forms of birth control and demonstrate their ability to come back regularly for follow up appointments."